Old Web
English
Sign In
Acemap
>
authorDetail
>
Xavier de Lamballerie
Xavier de Lamballerie
French Institute of Health and Medical Research
Virology
Biology
Favipiravir
safety profile
Hemorrhagic Fevers
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
2021
Viruses
Cyrille Mathieu
Franck Touret
Clémence Jacquemin
Yves L. Janin
Antoine Nougairéde
Manon Brailly
Magalie Mazelier
Didier Décimo
Virginie Vasseur
Aymeric Hans
jose-carlos Valle-Casuso
Xavier de Lamballerie
Branka Horvat
Patrice André
Mustapha Si-Tahar
Vincent Lotteau
Pierre-Olivier Vidalain
Show All
Source
Cite
Save
Citations (0)
Monitoring the proportion infected by SARS-CoV-2 from age-stratified hospitalisation and serological data
2021
medRxiv
Nathanaël Hozé
Juliette Paireau
Nathanael Lapidus
Cecile Tran Kiem
Henrik Salje
Gianluca Severi
Mathilde Touvier
Marie Zins
Xavier de Lamballerie
Daniel Lévy-Bruhl
Fabrice Carrat
Simon Cauchemez
Show All
Source
Cite
Save
Citations (1)
Implementation strategies for the first licensed dengue vaccine: A meeting report.
2021
Vaccine
Noah Fongwen
Isabelle Delrieu
Leong Hoe Ham
Duane J. Gubler
Anna P. Durbin
Eng Eong Ooi
Rosanna W. Peeling
Stefan Flasche
Kenneth Hartigan-Go
Samuel Clifford
Carlos Torres Martinez
Xavier de Lamballerie
Till Bärnighausen
Annelies Wilder-Smith
Show All
Source
Cite
Save
Citations (0)
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.
2020
PLOS Neglected Tropical Diseases
Denis Malvy
Anne-Marie Taburet
Xavier de Lamballerie
Fabrice Extramiana
Show All
Source
Cite
Save
Citations (5)
1